MARKET REPORTS
Mass Spectrometry: A Survey of End-Users
Published: September 2023, 118 pages
Survey Demographics. Overall, 112 complete and qualified responses were obtained. Survey respondents represented 9 end markets, which were consolidated into 3 industries for analysis. Over half of the respondents were from pharma/bio or CRO labs. Nearly one-third of the respondents were from basic research labs and nearly another third from analytical services. More than half of the respondents had at least 10 years of experience with MS; more than three-fourths had at least 7 years of experience
Purchasing Considerations. This report identifies the key parameters that drive MS purchase decisions.
Vendor Favorability Ratings. This study provides a benchmark for brand awareness and favorability of the top tier MS companies, as well as secondary companies.
Table of Contents
- Introduction
- Executive Summary
- Industry Benchmarks and Trends
- End-User Perspectives
A. Survey Demographics
B. Usage & Vendor Familiarity
C. HR/UHR MS
D. Triple Quad LC/MS
E. Single Quad LC/MS
F. GC/MS
G. User Comments: Innovations in MS - Market Demand: Mass Spectrometry
A. HR/UHR MS Demand
B. TQ LC/MS
C. SQ LC/MS
D. GC/MS
E. MALDI-TOF MS
Primary objectives of this market analysis
- Understand the preferences, patterns, and trends of scientists using mass spectrometry
- Quantitatively describe the MS business for 2022
- Project market size & growth for 2023 – 2028
- Estimate revenues of the leading suppliers for 2022
- Identify opportunities, challenges and end-user preferences
Other objectives of this report
- Analyze economic factors driving the mass spectrometry market
- Identify leading suppliers in the market
- Explore technological factors impacting products
Sources of information for this report
- TDA proprietary database on analytical technologies
- Manufacturers earnings calls, press releases, investor presentations, annual filings
- Publications, NIH grants
- Conference proceedings
- Trade reports
- Economic data (US Census Bureau, WEO, Pitchbook)
Products
- High-resolution/Ultra-high resolution LC/MS – HR/UHR MS
- QTOF, IMS-QTOF, timsTOF, Orbitrap
- Tandem or triple quad LC/MS – TQ LC/MS
- Single quad LC/MS – SQ LC/MS
- Gas chromatography/Mass spectrometry – GC/MS
- Other MS technologies
- Imaging MS
- Direct-inject MS
Geographies
- North America
- USA & Canada
- Europe
- Western Europe: includes Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK
- Eastern Europe: includes Armenia, Belarus, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Georgia, Hungary, Latvia, Lithuania, Macedonia, Malta, Moldova, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Ukraine
- Asia-Pacific
- China
- Other Asia-Pacific: includes Australia, Azerbaijan, Bangladesh, Cambodia, India, Indonesia, Japan, Kazakhstan, Korea, Kyrgyzstan, Laos, Malaysia, Myanmar, Nepal, New Zealand, Pakistan, Philippines, Singapore, Sri Lanka, Taiwan, Tajikistan, Thailand, Uzbekistan, Vietnam
- Rest of World (ROW)
- Latin America: includes Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, French Guiana, Grenada, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, Venezuela
- Middle East: includes Algeria, Bahrain, Egypt, Iraq, Israel, Jordan, Kuwait, Lebanon, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, Turkey, UAE, Yemen
- Africa
End-Markets
- Pharma/Bio
- Pharmaceutical, biopharma, biotechnology, contract labs (CxOs – research, development, manufacturing)
- Public Sector
- Academia, government, utilities
- Industrial
- Chemical, plastics, petrochemical, oil & gas, semiconductor/electronics
- Environmental & Food
- Agriculture, environmental, food & beverage, cannabis
- Applied/Other
- Clinical, diagnostics, hospitals, security, forensics
Questions?
Please contact:
Glenn Cudiamat, President & CEO
glenn@tdaresearch.com
+1 (310) 871-3768